These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 682371)

  • 41. Experimental radiation therapy and apparent radioresistance of autochthonous tumors subcutaneously induced with 3-methylcholanthrene in mice.
    Tanooka H; Hoshino H; Tanaka K; Nagase M
    Cancer Res; 1980 Jul; 40(7):2547-51. PubMed ID: 7388810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.
    Shimada S; Yano O; Inoue H; Kuramoto E; Fukuda T; Yamamoto H; Kataoka T; Tokunaga T
    J Natl Cancer Inst; 1985 Mar; 74(3):681-8. PubMed ID: 3856070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic effects of methylcholanthrene in mice. II. Immune responses to sheep red cells.
    Schreiber R; Stern K
    Oncology; 1984; 41(6):436-41. PubMed ID: 6390287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
    Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
    J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological status.
    Trutin-Ostović C; Golubić M; Matović M; Marusić M
    Cancer Immunol Immunother; 1986; 23(2):130-6. PubMed ID: 3490910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of peritoneal macrophages by oil-attached cell-wall skeleton of BCG and Nocardia rubra.
    Masuno T; Ito M; Ogura T; Hirao F; Yamawaki M; Azuma I; Yamamura Y
    Gan; 1979 Apr; 70(2):223-7. PubMed ID: 381089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor.
    Hanna MG; Peters LC
    Cancer; 1975 Oct; 36(4):1298-304. PubMed ID: 1175128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced antitumor effect of Bacillus Calmette-Guérin in combination with fibrinogen on urinary bladder tumor.
    Mizutani Y; Nio Y; Fukumoto M; Yoshida O
    J Urol; 1994 May; 151(5):1420-6. PubMed ID: 8158799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrophages in resistance to rickettsial infections: protection against lethal Rickettsia tsutsugamushi infections by treatment of mice with macrophage-activating agents.
    Nacy CA; Meltzer MS
    J Leukoc Biol; 1984 Apr; 35(4):385-96. PubMed ID: 6584528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCG immunotherapy: effects of dose and route of administration on survival of mice bearing established tumors.
    Codish SD; Monaco AP
    J Surg Oncol; 1978; 10(5):447-55. PubMed ID: 732331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine.
    Calabrese KS; da Costa SC
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 1():49-56. PubMed ID: 1343799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunotherapy of autochthomous rat methylcholanthrene-induced sarcomas with a mixture of allogeneic tumor cells and BCG-CWS.
    Kudo H; Suga M; Waga T; Ogasawara M; Sato T; Usubuchi I
    Tohoku J Exp Med; 1980 Jan; 130(1):49-53. PubMed ID: 7368205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for host-mediated antitumor activity in the treatment of experimental tumor with a hot water extract from BCG.
    Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1982 Jan; 136(1):67-74. PubMed ID: 7071830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.
    Castés M; Lynch NR; Lespinats G; Orbach-Arbouys S
    Br J Cancer; 1981 Dec; 44(6):828-37. PubMed ID: 6459797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. I. Effect of different BCG treatments on cytotoxicity mediated by T-cells and macrophages.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1978 May; 60(5):1059-68. PubMed ID: 305965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of oral and rectal BCG administration on chemically-induced rat intestinal carcinoma.
    Martin MS; Justrabo E; Lagneau A; Michel MF; Martin F
    Digestion; 1977; 16(1-2):189-93. PubMed ID: 615732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.